Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020

This cross-sectional study uses data from the US Food and Drug Administration (FDA) to review the postmarketing requirements and commitments attached to new vaccines approved for use in the past 15 years in the United States.

Detalles Bibliográficos
Autores principales: Moneer, Osman, Lee, ChangWon C., Avorn, Jerry, Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087952/
https://www.ncbi.nlm.nih.gov/pubmed/33929526
http://dx.doi.org/10.1001/jamanetworkopen.2021.8530
_version_ 1783686760171044864
author Moneer, Osman
Lee, ChangWon C.
Avorn, Jerry
Kesselheim, Aaron S.
author_facet Moneer, Osman
Lee, ChangWon C.
Avorn, Jerry
Kesselheim, Aaron S.
author_sort Moneer, Osman
collection PubMed
description This cross-sectional study uses data from the US Food and Drug Administration (FDA) to review the postmarketing requirements and commitments attached to new vaccines approved for use in the past 15 years in the United States.
format Online
Article
Text
id pubmed-8087952
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-80879522021-05-06 Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020 Moneer, Osman Lee, ChangWon C. Avorn, Jerry Kesselheim, Aaron S. JAMA Netw Open Research Letter This cross-sectional study uses data from the US Food and Drug Administration (FDA) to review the postmarketing requirements and commitments attached to new vaccines approved for use in the past 15 years in the United States. American Medical Association 2021-04-30 /pmc/articles/PMC8087952/ /pubmed/33929526 http://dx.doi.org/10.1001/jamanetworkopen.2021.8530 Text en Copyright 2021 Moneer O et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Moneer, Osman
Lee, ChangWon C.
Avorn, Jerry
Kesselheim, Aaron S.
Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
title Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
title_full Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
title_fullStr Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
title_full_unstemmed Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
title_short Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
title_sort characteristics of postmarketing studies for vaccines approved by the us food and drug administration, 2006-2020
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087952/
https://www.ncbi.nlm.nih.gov/pubmed/33929526
http://dx.doi.org/10.1001/jamanetworkopen.2021.8530
work_keys_str_mv AT moneerosman characteristicsofpostmarketingstudiesforvaccinesapprovedbytheusfoodanddrugadministration20062020
AT leechangwonc characteristicsofpostmarketingstudiesforvaccinesapprovedbytheusfoodanddrugadministration20062020
AT avornjerry characteristicsofpostmarketingstudiesforvaccinesapprovedbytheusfoodanddrugadministration20062020
AT kesselheimaarons characteristicsofpostmarketingstudiesforvaccinesapprovedbytheusfoodanddrugadministration20062020

Ejemplares similares